Evidence map›Paper›PMID 31293540›Full record

ArticleFrontiers in microbiology2019

Prediction of T4SS Effector Proteins for

Zhila Esna Ashari, Kelly A Brayton, Shira L Broschat

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Adaptation ofmSphere · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Analysis of the Type 4 Effectome across the GenusInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Ticks: More Than Just a Pathogen Delivery Service.Frontiers in cellular and infection microbiology · 2021
    Article
  17. Computational prediction of secreted proteins in gram-negative bacteria.Computational and structural biotechnology journal · 2021
    Review
  18. Article
  19. Global Transcription Profiles ofFrontiers in veterinary science · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhila Esna AshariSchool of Electrical Engineering and Computer Science, Washington State University, Pullman, WA, United States.
Kelly A BraytonSchool of Electrical Engineering and Computer Science, Washington State University, Pullman, WA, United States.
Shira L BroschatSchool of Electrical Engineering and Computer Science, Washington State University, Pullman, WA, United States.
Washington State University · US

Funding

Tick-Mammal Interface of Human Granulocytic AnaplasmosisR01AI042792 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MUNDERLOH, ULRIKE GERTRUD · 2005 to 2020
$8.7M
NIAID NIH HHS R01 AI042792
6 · The paper itself

Abstract

Type IV secretion systems (T4SS) are used by a number of bacterial pathogens to attack the host cell. The complex protein structure of the T4SS is used to directly translocate effector proteins into host cells, often causing fatal diseases in humans and animals. Identification of effector proteins is the first step in understanding how they function to cause virulence and pathogenicity. Accurate prediction of effector proteins via a machine learning approach can assist in the process of their identification. The main goal of this study is to predict a set of candidate effectors for the tick-borne pathogen

Indexed as

Anaplasma phagocytophilummachine learningOPT4e softwareprotein predictionT4SS effector proteins

Identifiers

PMID31293540
PMCPMC6598457
OpenAlexW2953153481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.